BWAY Brainsway Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: BWAY

Price (delayed)

$5.78

Market cap

$96.07M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.26

Enterprise value

$85.28M

brainsway is a leading global neurmodulation company with headquarters in jerusalem and the us. our patented breakthrough technology has already treated over 10,000 patients, and has helped usher in a ...

Highlights
BWAY's net income has soared by 69% YoY and by 49% QoQ
BWAY's EPS has surged by 68% year-on-year and by 46% since the previous quarter
BWAY's quick ratio is down by 21% year-on-year and by 11% since the previous quarter
The equity has declined by 8% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://brainsway.com

Key stats

What are the main financial stats of BWAY
Market
Shares outstanding
16.62M
Market cap
$96.07M
Enterprise value
$85.28M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.3
Price to sales (P/S)
3.01
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.68
Earnings
Revenue
$31.79M
EBIT
-$2.79M
EBITDA
-$1.45M
Free cash flow
-$1.1M
Per share
EPS
-$0.26
Free cash flow per share
-$0.07
Book value per share
$2.52
Revenue per share
$1.92
TBVPS
$3.81
Balance sheet
Total assets
$62.97M
Total liabilities
$21.39M
Debt
$0
Equity
$41.58M
Working capital
$45.7M
Liquidity
Debt to equity
0
Current ratio
5.68
Quick ratio
5.13
Net debt/EBITDA
7.44
Margins
EBITDA margin
-4.6%
Gross margin
73.9%
Net margin
-13.2%
Operating margin
-15.6%
Efficiency
Return on assets
-6.9%
Return on equity
-10%
Return on invested capital
-16.5%
Return on capital employed
-5.2%
Return on sales
-8.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

BWAY stock price

How has the Brainsway stock price performed over time
Intraday
-0.17%
1 week
21.43%
1 month
2.85%
1 year
290.54%
YTD
-10.8%
QTD
9.26%

Financial performance

How have Brainsway's revenue and profit performed over time
Revenue
$31.79M
Gross profit
$23.48M
Operating income
-$4.96M
Net income
-$4.2M
Gross margin
73.9%
Net margin
-13.2%
The company's net margin has surged by 73% YoY and by 54% QoQ
BWAY's net income has soared by 69% YoY and by 49% QoQ
Brainsway's operating margin has surged by 67% YoY and by 53% QoQ
The operating income has soared by 61% YoY and by 48% from the previous quarter

Growth

What is Brainsway's growth rate over time

Valuation

What is Brainsway stock price valuation
P/E
N/A
P/B
2.3
P/S
3.01
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.68
BWAY's EPS has surged by 68% year-on-year and by 46% since the previous quarter
The P/B is 64% above the last 4 quarters average of 1.4 but 8% below the 5-year quarterly average of 2.5
The equity has declined by 8% year-on-year
BWAY's P/S is 43% above its last 4 quarters average of 2.1 but 11% below its 5-year quarterly average of 3.4
The company's revenue rose by 17% YoY and by 10% QoQ

Efficiency

How efficient is Brainsway business performance
BWAY's ROIC has soared by 83% QoQ and by 71% YoY
BWAY's return on sales has surged by 79% year-on-year and by 70% since the previous quarter
The ROA has soared by 64% YoY and by 48% from the previous quarter
The ROE has soared by 62% YoY and by 48% from the previous quarter

Dividends

What is BWAY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BWAY.

Financial health

How did Brainsway financials performed over time
The total assets is 194% greater than the total liabilities
BWAY's quick ratio is down by 21% year-on-year and by 11% since the previous quarter
The current ratio has contracted by 20% YoY and by 11% from the previous quarter
The company's debt is 100% lower than its equity
The equity has declined by 8% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.